XML 32 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Sep. 30, 2014
STOCKHOLDERS' EQUITY [Abstract]  
Schedule of Stock Option Activity
 
Three months ended September 30, 2014 (Unaudited)
 
 
Number
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Terms (in years)
   
Aggregate Intrinsic Value Price
 
Options outstanding at beginning of period
    1,862,099     $ 3.73              
Options exercised
    (3,000 )   $ 0.62              
Options forfeited
    -                      
Options outstanding at end of the period
    1,859,099     $ 3.73       2.87     $ 929  
Options exercisable at the end of the period
    1,859,099     $ 3.73       2.87     $ 929  
Options vested
    1,859,099     $ 3.73       2.87     $ 929  
Schedule of Stock Option and Warrant Activity
 
Three months ended September 30, 2014 (Unaudited)
 
 
Number
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Terms (in years)
   
Aggregate Intrinsic Value Price
 
Options and warrants outstanding at beginning of period
    252,000     $ 5.19              
Options and warrants outstanding at end of the period
    252,000     $ 5.19       3.71     $ 300  
                                 
Options and warrants exercisable at the end of the period
    252,000     $ 5.19       3.71     $ 300  
                                 
Options and warrants vested and expected to vest
    252,000     $ 5.19       3.71     $ 300  
Options and warrants [Member]
 
Stockholders Equity Note [Line Items]  
Schedule of Stock-based Compensation Expenses
 
Three months ended September 30,
 
 
2014 (Unaudited)
   
2013 (Unaudited)
 
Research and development expenses
  $ 1     $ -  
General and administrative expenses
    -       2  
    $ 1     $ 2  
Restricted stock units [Member]
 
Stockholders Equity Note [Line Items]  
Schedule of Unvested Restricted Stock Units
   
Number
 
Unvested at the beginning of period
    1,589,432  
Granted
    24,499  
Forfeited
    (8,725 )
Vested
    (439,078 )
Unvested at the end of the period
    1,166,128  
Expected to vest after  September 30, 2014
    1,141,828  
Schedule of Stock-based Compensation Expenses
 
Three months ended September 30,
 
 
2014 (Unaudited)
   
2013 (Unaudited)
 
Research and development expenses
  $ 333     $ 126  
General and administrative expenses
    702       1,048  
    $ 1,035     $ 1,174  
Consultant restricted stock units [Member]
 
Stockholders Equity Note [Line Items]  
Schedule of Unvested Restricted Stock Units
   
Number
 
Unvested at the beginning of period
    15,250  
Granted
    5,000  
Forfeited
    -  
Vested
    (7,875 )
Unvested at the end of the period
    12,375  
Expected to vest after September 30, 2014
    12,375  
Schedule of Stock-based Compensation Expenses
 
Three months ended September 30,
 
 
2014 (Unaudited)
   
2013 (Unaudited)
 
Research and development expenses
  $ 20     $ -  
General and administrative expenses
    4       -  
    $ 24     $ -